All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for SICKLE CELL DISEASE ASSOCIATION OF AMERICA · national organization dedicated to supporting people living with sickle cell disease

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $20,000.00 income · posted Jul 18, 2025

Official filing document

Bills named in this filing 6

HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
S 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
S 721
Sickle Cell Disease Comprehensive Care Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act
HR 1
For the People Act of 2021

Lobbying activity 4

Health Issues

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 1796/S. 735) Policies related to the social security disability programs, including National Academies of Science Education and Medicine Review of sickle cell disease criteria for social security disability programs.

Medicare/Medicaid

Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721) Accelerating Kids Access to Care Act (H.R. 1509/S. 752) Medicaid eligibility and coverage for needed services for people living with sickle cell disease H.R. 1, One Big Beautiful Bill Act

Budget/Appropriations

Funding for federal sickle cell disease programs FY25 and FY26 House and Senate Labor-HHS Appropriations bills Letter to Secretary Kennedy regarding the reductions in force at the Centers for Disease Control and Preventions Division of Blood Disorders and Public Health Genomics

Insurance

H.R. 1, One Big Beautiful Bill Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.